Transcriptional regulation of hypoxia-inducible factor 1α by HIPK2 suggests a novel mechanism to restrain tumor growth

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 2, 2009, Pages 368-377

  Nardinocchi, Lavinia ^a   Puca, Rosa ^a   Guidolin, Diego ^b   Belloni, Anna S ^b   Bossi, Gianluca ^a   Michiels, Carine ^c   Sacchi, Ada ^a   Onisto, Maurizio ^d   D'Orazi, Gabriella ^a,e  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^c UNIVERSITY OF NAMUR   (Belgium)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

ChIP; HIF 1 mRNA; HIF 1 promoter; HIPK2; Luciferase activity; RNA interference

Indexed keywords

HISTONE DEACETYLASE 1; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GENE CONSTRUCT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION; XENOGRAFT;

ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58549105909     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.10.013     Document Type: Article

References (50)

1. Kim Y.H., Choi C.Y., Lee S.J., Conti M.A., and Kim Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 273 (1998) 25875-25879
2. Choi C.Y., Kim Y.H., Kwon H.J., and Kim Y. The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J. Biol. Chem. 274 (1999) 33194-33197
3. Harada J., Kokura K., Kanei-Ishii C., Nomura T., Khan M.M., Kim Y., and Ishii S. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation. J. Biol. Chem. 3 (2003) 38998-39005
4. Zhang Q., Yoshimatsu Y., Hildebrand J., Frisch S.M., and Goodman R.H. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115 (2003) 177-186
5. Wiggings A.K., Wei G., Doxakis E., Wong C., Tang A.A., Zang K., Luo E.J., Neve R.L., Reichardt L.F., and Huang E.J. Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. J. Cell Biol. 167 (2004) 257-267
6. D'Orazi G., Sciulli M.G., Di Stefano V., Riccioni S., Frattini M., Falcioni R., Bertario L., Sacchi A., and Patrignani P. Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells. Clin. Cancer Res. 12 (2006) 735-741
7. Kanei-Ishii C., Ninomiya-Tsuji J., Tanikawa J., Nomura T., Ishitani T., Kishida S., Kokura K., Kurahashi T., Ichikawa-Iwata E., Kim Y., Matsumoto K., and Ishii S. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 18 (2004) 816-836
8. D'Orazi G., Cecchinelli B., Bruno T., Manni I., Higashimoto Y., Saito S., Gostissa M., Coen S., Marchetti A., Del Sal G., Piaggio G., Fanciulli M., Appella E., and Soddu S. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser46 and mediates apoptosis. Nat. Cell Biol. 4 (2002) 11-19
9. Hofmann T.G., Moller A., Sirma H., Zentgraf H., Taya Y., Droge W., Will H., and Schmitz M.L. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4 (2002) 1-10
10. Cecchinelli B., Lavra L., Rinaldo C., Iacovelli S., Gurtner A., Gasbarri A., Ulivieri A., Del Prete F., Trovato M., Piaggio G., Bartolazzi A., Soddu S., and Sciacchitano S. Repression of the antiapoptotic molecule Galectin-3 by Homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. Mol. Cell. Biol. 26 (2006) 4746-4757
11. Pierantoni G.M., Bulfone A., Pentimalli F., Fedele M., Iuliano R., Santoro M., Chiariotti L., Ballabio A., and Fusco A. The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues. Biochem. Biophys. Res. Commun. 290 (2002) 942-947
12. Pierantoni G.M., Rinaldo C., Mottolese M., Di Benedetto A., Esposito F., Soddu S., and Fusco A. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J. Clin. Invest. 117 (2007) 693-702
13. Wei G., Ku S., Ma G.K., Saito S., Tang A.A., Zhang J., Mao J.-H., Appella E., Ballmain A., and Huang E.J. HIPK2 represses β-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13040-13045
14. Li X.-L., Arai Y., Harada H., Shima Y., Yoshida H., Rokudai S., Aikawa Y., Kimura A., and Kitabayashi I. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription. Oncogene 26 (2007) 7231-7239
15. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
16. Xu Q., Briggs J., Park S., Niu G., Kotylewski M., Zhang S., Gritsko T., Turkson J., Kay H., Semenza G.L., Cheng J.Q., Jove R., and Yu H. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24 (2005) 5552-5560
17. Falkman J. Tumor angiogenesis. In: Holland J.F., Bast Jr. R.C., Morton D.L., Frei III E., Kufe D.W., and Weichselbaum R.R. (Eds). Cancer Medicine (1997), Williams & Wilkins, Baltimore, MD. 181-204
18. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 20 (2002) 4368-4380
19. Wang G.L., Jiang B.-H., Rue E.A., and Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. 92 (1995) 5510-5514
20. Jiang B.H., Semenza G.L., Bauer H., and Marti H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 271 (1996) C1172-C1180
21. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16 (1996) 4604-4613
22. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., and Kershert E. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 394 (1998) 485-490
23. Ryan H.E., Lo J., and Johnson R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17 (1998) 3005-3015
24. Semenza G.L. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov. Today 12 (2007) 853-859
25. Di Stefano V., Rinaldo C., Sacchi A., Soddu S., and D'Orazi G. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp. Cell Res. 293 (2004) 311-320
26. Di Stefano V., Soddu S., Sacchi A., and G'Orazi D. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after non-apoptotic DNA damage. Oncogene 24 (2005) 5431-5442
27. Wiznerowicz M., and Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77 (2003) 8957-8961
28. Zufferey R., Nagy D., Mandel R.J., Naldini L., and Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15 (1997) 871-875
29. Ferrara N. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
30. Onisto M., Slongo M.L., Gregnanin L., Gastaldi T., Carli M., and Rosolen A. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Int. J. Oncol. 27 (2005) 791-798
31. Di Stefano V., Mattiussi M., Sacchi A., and D'Orazi G. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations. FEBS Lett. 579 (2005) 5473-5480
32. Iyer N.V., Leung S.W., and Semenza G.L. The human hypoxia-inducible factor 1α gene: HIF1A structure and evolutionary conservation. Genomics 52 (1998) 159-165
33. Minet E., Ernest I., Michel G., Roland I., Remacle J., Raes M., and Michiels C. HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5′UTR. Biochem. Biophys. Res. Commun. 261 (1999) 534-540
34. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7 (1987) 2754-2756
35. Zhong X.-S., Liu L.-Z., Skinner H.D., Cao Z., Ding M., and Jiang B.-H. Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells. Biochem. Biophys. Res. Commun. 358 (2007) 92-98
36. Mazure N.M., Chen E.Y., Yeh P., Laderoute K.R., and Giaccia A.J. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56 (1996) 3436-3440
37. Guidolin D., Vacca A., Nussdorfer G.G., and Ribatti D. A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of Docetaxel by using the matrigel assay in vitro. Microvasc. Res. 67 (2004) 117-124
38. Choi D.W., seo Y.-M., Kim E.-A., Sung K.S., Ahn J.W., Park S.-J., Lee S.-R., and Choi C.Y. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 (HIPK2) by WD40-repeat/SOCS box protein WSB-1. J. Biol. Chem. 283 (2008) 4682-4689
39. Winter M., Sombroek D., Dauth I., Moehlenbrink J., Scheuermann K., Crone J., and Hofmann T.G. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat. Cell Biol. 10 (2008) 812-824
40. Bonello S., Zahringer C., BelAiba R.S., Djordevic T., Hess J., Michiels C., Kietmann T., and Gorlach A. Reactive oxygen species activate the HIF-1α promoter via a functional NFkB site. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 755-761
41. Zhang X., Gaspard J.P., and Chung D.C. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 61 (2001) 6050-6054
42. Puca R., Nardinocchi L., and D'Orazi G. Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2. J. Exp. Clin. Cancer Res. 27 (2008) 22
43. Aikawa Y., Nguyen L.A., Isono K., Takakura N., Tagata Y., Schmitz M.L., Kosei H., and Kitabayashi I. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J. 25 (2006) 3955-3965
44. Rinaldo C., Prodosmo A., Siepi F., and Soddu S. HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochem. Cell. Biol. 85 (2007) 411-418
45. Pagé E.L., Robitaille G.A., Pouysségur J., and Richard D.E. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 277 (2002) 48403-48409
46. Jiang B.H., Agani F., Passaniti a., and Semenza G.L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 57 (1997) 5328-5335
47. Blouin C.C., Page E.L., Soucy G.M., and Richard D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1α. Blood 103 (2004) 1124-1130
48. Liu Q., Moller U., Flugel D., and Kietzmann T. Induction of plasminogen activator inhibitor 1 gene expression by intracellular calcium via hypoxia-inducible factor 1. Blood 104 (2004) 3993-4001
49. Busca' R., Berra E., Giaggioli C., Khaled M., Bille K., Marchetti B., Thyss R., Fitsialos G., Larribere L., Bertolotto C., Virolle T., Barbry P., Pouyssegur J., Ponzio G., and Ballotti R. Hypoxia-inducible factor 1 α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J. Cell Biol. 170 (2005) 49-59
50. Semenza G.L. Involvement of hypoxia-inducible factor 1 in human cancer. Nat. Rev., Cancer 3 (2003) 721-732